RK
Rupali Ketan Pachorkar
About Rupali Ketan Pachorkar
Data last updated:
Rupali Ketan Pachorkar is a Director at Metamed Pharma Private Limited (since 2023). The company operates in Trading. Metamed Pharma Private Limited reported revenue of ₹75,400 (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Metamed Pharma Private Limited U51909MH2022PTC389791 | Director | 19 Apr 2023 | 2022 | ₹75,400 (FY 2023) | Active |
Board colleagues of Rupali Ketan Pachorkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhagyashri Chandrashekhar Sabe | 09724876 | Metamed Pharma Private Limited | Director |
| Kunal Deelip Sapkale | 07586114 | Metamed Pharma Private Limited | Director |
| Lalit Dagadu Sonawane | 09724877 | Metamed Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rupali Ketan Pachorkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rupali Ketan Pachorkar
Rupali Ketan Pachorkar currently holds 1 directorship: Metamed Pharma Private Limited (Director, since 19 Apr 2023, revenue ₹75,400 (FY 2023)).
Rupali Ketan Pachorkar was first appointed on 19 Apr 2023 as Director at Metamed Pharma Private Limited.
The current boards of Rupali Ketan Pachorkar's companies include Bhagyashri Chandrashekhar Sabe (Metamed Pharma Private Limited), Kunal Deelip Sapkale (Metamed Pharma Private Limited), Lalit Dagadu Sonawane (Metamed Pharma Private Limited).